Rituximab Completed Phase 3 Trials for Pemphigus

IndicationsStatusPurposePhase
CompletedNot Available3
clinicaltrials.gov IdentifierTitleDrugs
NCT01299857Long-term Clinical and Biological Evaluation of Patients With Severe Forms of Pemphigus Treated by Rituximab